Cellebrite DI .(CLBT)
Search documents
Cellebrite DI Ltd. (CLBT) Is Up 20.78% in One Week: What You Should Know
Zacks Investment Research· 2024-02-19 18:00
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...
Cellebrite DI .(CLBT) - 2023 Q4 - Earnings Call Transcript
2024-02-15 17:01
Financial Data and Key Metrics - Q4 revenue grew 26% YoY to $93 million, driven by a 26% increase in subscription software revenue [19] - Adjusted EBITDA for Q4 was $22.27 million, representing a 24% margin [19] - Non-GAAP EPS for Q4 was $0.11 [19] - Cash and investments at the end of 2023 totaled $332 million, a 62% increase from the end of 2022 [19] - Full-year 2023 revenue increased 20% to $325.1 million, with subscription revenue growing 30% [152] - Full-year adjusted EBITDA was $61.9 million, representing a 19% margin [38] - ARR grew 27% YoY to $315.7 million in Q4 and $316 million for the full year [19][60] Business Line Performance - Subscription revenue accounted for 85% of total revenue in 2023, with perpetual license revenue declining 36% [152] - Cloud-based revenue grew rapidly in 2023, though it represented less than 10% of total revenue [12] - Pathfinder deals reached a record number in Q4, with approximately 200 agencies now using the solution [27] - Inseyets, a new solution, has seen strong interest, with upgrades contributing to a 65% ARR increase at one national police force [52] Market Performance - Americas accounted for 53% of total ARR in 2023, followed by EMEA at 36% and Asia-Pacific at 11% [36] - ARR growth in the Americas was 30%, EMEA grew 23%, and Asia-Pacific increased 29% [36] - A large deal with a Western European national police force grew ARR by more than 25% [22] Strategy and Industry Competition - The company is focusing on expanding its Case-to-Closure (C2C) platform, which integrates digital forensic and investigative tools [18][26] - Investments in cloud infrastructure and FedRAMP certification are expected to open up more federal opportunities [25] - The company plans to scale its SaaS offerings, including cloud-enabling previously on-prem solutions and developing cloud-native offerings [25] - Inseyets is positioned as a game-changer, enabling customers to complete examinations up to twice as fast as before [9] Management Commentary on Operating Environment and Future Outlook - The company expects Q1 2024 revenue to range between $83 million and $88 million, representing 17% to 24% YoY growth [41] - Full-year 2024 revenue is expected to range from $370 million to $385 million, with ARR targets between $380 million and $400 million [153] - Adjusted EBITDA for 2024 is anticipated to be between $70 million and $80 million, with margins of 19% to 21% [42] - The company is optimistic about improving profitability and expects higher adjusted EBITDA margins in the second half of 2024 [42] Other Important Information - The company plans to expand its workforce by approximately 15% in 2024, focusing on go-to-market and innovation initiatives [13] - FedRAMP certification is a key milestone expected to unlock additional federal opportunities [119][120] - The company is exploring inorganic growth opportunities, including technological tuck-ins and larger acquisitions [112] Q&A Summary Question: Inseyets Pricing and Productivity Impact - Inseyets is priced 20% to 25% higher than legacy solutions, with additional modules contributing to higher value [104] - The company expects Inseyets to drive significant growth, with upgrades and add-on modules contributing to ARR expansion [20][24] Question: Subscription Revenue Benchmark - Subscription revenue is expected to remain around 85% of total revenue, with perpetual licenses becoming negligible [81][142] Question: Pathfinder and Guardian Contribution - Pathfinder and Guardian are emerging growth engines, with Pathfinder deals growing significantly in Q4 [27][90] - Both solutions are expected to grow faster than the core Inseyets offering, contributing to ARR growth in 2024 [106] Question: FedRAMP Market Opportunity - FedRAMP certification is expected to double the company's federal business by enabling access to additional buying centers [132] Question: Training and Customer Adoption - Training is essential for customer adoption, especially in law enforcement, and is integrated into the company's post-sale customer experience strategy [78][89] Question: M&A Strategy - Inorganic growth is part of the company's long-term strategy, with potential targets being evaluated [112] Question: Competitive Pricing Dynamics - The company operates in a value-based market, with competitors also increasing prices systematically [115]
Cellebrite DI .(CLBT) - 2023 Q4 - Earnings Call Presentation
2024-02-15 14:27
් Cellebrite Q4 2023 RESULTS CA February 15, 2024 :: Cellebrite DISCLAIMER GROWTH PROSPECTS STRATEGIC PRIORITIES & CUSTOMER SUCCESS February 15, 2024 Q4 2023 574 M Q4 22 This presentation las been presend tyc Gelebrite D Lut. (Inte "Company") solely for rinfrmalinal pupuses. Kis not, and sfruit not te assumed o be, complete. This presentat This presentainn is not drienced at, or rineanded for discilidulin no or resear or entily that is a citien or resident or koaliy, state, county or other jicsdiction where ...
Cellebrite: Growth, Profits, And Consistency
Seeking Alpha· 2024-02-14 20:15
Busakorn Pongparnit/Moment via Getty Images Introduction Cellebrite DI Ltd. (NASDAQ:CLBT) is an Israeli company that specializes in digital forensics data extraction, analytics and management. Their primary digital forensics software product, Inseyets (launched in January 2024), allows law enforcement to connect its software to a mobile device like a cell phone or tablet and securely access the device and extract data from it. The data is then decoded, reviewed, shared and analyzed with different products i ...
Cellebrite DI .(CLBT) - 2024 Q1 - Quarterly Report
2024-02-14 16:00
● GAAP gross profit and gross margin of $78.1 million and 84.0%, respectively; Non-GAAP gross profit and gross profit margin of $78.6 million and 84.5%, respectively Full-Year 2023 Financial Highlights ● GAAP net loss of $81.1 million; Non-GAAP net income of $60.9 million Innovation · In mid-November 2023, Cellebrite sponsored and participated in Milipol, the preeminent global law enforcement and homeland security event held in Paris. Supplemental financial information can be found on the Investor Relations ...
Cellebrite DI .(CLBT) - 2023 Q4 - Annual Report
2024-02-14 16:00
Record ARR of $315.7 million, up 27% year-over-year; TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, February 15, 2024 – Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2023. Fourth-Quarter Financial Highlights ● Revenue of $93.0 million, up 26% year-over-year ● GAAP gross profit and gross margin of $78.1 million and 84.0%, respectively; Non-GAAP gross pr ...
Will Cellebrite DI Ltd. (CLBT) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research· 2024-01-19 18:11
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cellebrite DI Ltd. (CLBT) , which belongs to the Zacks Technology Services industry, could be a great candidate to consider.This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 433.33%.For the last reported quarter, Cellebrite DI Ltd. C ...
Cellebrite DI .(CLBT) - 2023 Q3 - Earnings Call Transcript
2023-11-14 19:36
Cellebrite DI Ltd (NASDAQ:CLBT) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Andrew Kramer - VP, IR Yossi Carmil - Founder, CEO & Director Dana Gerner - CFO Conference Call Participants Michael Cikos - Needham & Company Jonathan Ho - William Blair & Company Jeff Van Rhee - Craig-Hallum Hugh Cunningham - TD Cowen Tal Liani - Bank of America Merrill Lynch Jamie Shelton - Deutsche Bank Douglas Bruehl - JPMorgan Chase & Co. Operator Welcome to the Cellebrite Third Quarter 2 ...
Cellebrite DI .(CLBT) - 2023 Q2 - Earnings Call Transcript
2023-08-08 15:33
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Andrew Kramer - Vice President-Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer Conference Call Participants Jeff Van Rhee - Craig Hallum Jamie Shelton - Deutsche Bank Tomer Zilberman - Bank of America Louie DiPalma - William Blair Mike Cikos - Needham and Company Operator Welcome to the Cellebrite's Second Quarter 2023 Financial Results Conference Ca ...
Cellebrite DI .(CLBT) - 2023 Q3 - Quarterly Report
2023-08-07 16:00
Revenues of $76.7 million, 23% year-over-year increase primarily due to 35% growth in subscription revenue; ARR of $273.7 million, up 28% year-over-year; Adjusted EBITDA of $11.1 million, 14.5% Adjusted EBITDA margin; Company increases 2023 outlook for revenue, ARR and adjusted EBITDA TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, August 8, 2023 – Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the thre ...